Stem cell-gene therapy shows promise in ALS safety trial

Investigators have developed an investigational therapy using support cells and a protective protein that can be delivered past the blood-brain barrier. This combined stem cell and gene therapy can potentially protect diseased motor neurons in the spinal cord of patients with amyotrophic lateral sclerosis, a fatal neurological disorder known as ALS or Lou Gehrig's disease.

from Top Health News -- ScienceDaily https://ift.tt/60rFgKk